REGENXBIO announces pricing of public offering of common stock
REGENXBIO announced pricing of an underwritten public offering of 2,700,000 shares of its common stock at the price of $65.00 per share. Gross proceeds are expected to be $175.5 million. REGENXBIO granted underwriters a 30-day option to purchase an additional 405,000 shares of common stock. August 10, 2018